Pharmaceutical Industry Information Portal



Flu Research Institute finishes pre-clinical tests of its COVID-19 vaccine

The Russian health ministry’s Smorodintsev Flu Research Institute has finished pre-clinical tests of its own coronavirus vaccine and plans to begin trials on volunteers...

Vladimir Rusinov: the Virus is Rapidly Mutating

Vladimir Rusinov, the Head of the Laboratory of Organic Synthesis of Ural Federal University, Corresponding Member of RAS, one of the creators of Triazavirin,...

China’s Zhifei says unit’s COVID shot shows 81.76% efficacy in late-stage trial

A COVID-19 vaccine developed by a unit of China's Chongqing Zhifei Biological Products (Zhifei) showed an 81.76% efficacy rate against COVID-19 cases of any degree of severity in a large, late-stage trial, Zhifei said on Friday.

Chumakov Center plans to double CoviVac production in October, says director general

The Chumakov Center plans to double the production of the CoviVac whole-virion vaccine against the coronavirus to 2.5 mln doses per month in October...

Pfizer halts distribution of anti-smoking drug after finding carcinogen

Pfizer Inc said on Thursday it is pausing distribution of its anti-smoking treatment, Chantix, after finding elevated levels of cancer-causing agents called nitrosamines in...

Expert Articles